EUMAR Medical Discuss a project

SPECIALIST WOUND-CARE CDMO

Eumar Medical is a leading specialist woundcare CDMO

Layered superabsorbent materia
Close view of laboratory formulation work
Operator working with controlled manufacturing equipment
EUMAR is a leading specialist UK-based CDMO, delivering resilient, innovative and agile R&D and manufacturing solutions to a global healthcare market We start with the clinical problem, not the end product. We work in partnership with our customers from day one, to develop resilient and enduring wound-care products, ensuring the route to market remains simple.Projects can enter the process at the stage that fits our customer’s needs.
Discuss a project
Operator working with controlled manufacturing equipment

RESILIENCE IN AN UNCERTAIN WORLD

As a rare UK-based onshore R&D and manufacturing operation, we have invested heavily in supply chain security and resilience in the face of rising geopolitical uncertainty. This gives our customers certainty in an uncertain world.

EUMAR OPERATING MODEL

Two specialist teams, one continuous pathway

Eumar Development Labs (R&D) and Eumar Technology (manufacturing) operate as a seamless entity, allowing for market-leading agility, innovation and supply chain resilience along the full development cycle, from concept to manufacturing.

EUMAR Development Labs

Delivering the right woundcare solution starts with the clinical challenge. So our agile approach to R&D allows us to work closely with our customers and respond to their requirements. In that way we remain flexible to their needs, developing a resilient product that will make a difference.
  1. 01Concept generation
  2. 02R&D and formulation
  3. 03Prototyping & optimisation
  4. 04Verification & validation
HANDOVER  ↓

Eumar Technology

We are a leading specialist in wound care, clean room technology and medical device manufacturing and packaging. Working with clients across the world, our expertise in super absorbent polymers, non-wovens, adhesives and ultrasonic technology has transformed how customers’ healthcare products are manufactured and arrived at market.
  1. 05Process scale up
  2. 06Clean room manufacturing
  3. 07Packaging and logistics
  4. 08Sterilisation

Delivering a customer-centric agile pathway

A PATHWAY WITH MORE THAN ONE BEGINNING

Eumar Medical’s agile approach to development and manufacture allows customers to enter our process at different stages, depending on their needs. From concept to prototype, our Development Labs will work in partnership with customers to design products that are resilient, effective and deliverable. Eumar Technology delivers the scale-up required by many customers, taking products from verification to manufacture and supply.

DEVELOPMENT LABS

TECHNOLOGY

  1. 01EARLY STAGEEntry possible
  2. 02Concept, formulation and feasibility
  3. 03DEVELOPMENT STAGEEntry possible
  4. 04Prototype, optimisation and verification
  5. 05SCALE STAGEEntry possible
  6. 06Process scale-up, manufacturing and supply
  7. 07Eumar Medical provides the end-to-end solution needed in today’s modern world.

SPECIALIST WOUND-CARE CONTEXT

Five areas of material and process focus.

Select an area to change the working study. Every specialist area remains visible as part of the wider EUMAR system.

SELECTED FOCUS

01   SELECTED SPECIALIST AREASuperabsorbents

Our manufacturing centre of excellence.

Superabsorbent technology is where our manufacturing heritage began, and it’s where we have more than 40 years of experience. We develop and manufacture superabsorbent cores tailored to the fluid-handling performance your product needs. Active substances can be built in where the clinical application calls for them.

  • Development of superabsorbent core materials
  • Integration of active substances
  • Fluid-handling optimisation, in a wide range of sizes and shapes
Laboratory specialist preparing and observing a formulation during development work

EXPERTISE IN ACTION

WoundSan®

Innovating the treatment of chronic skin wounds WoundSan® Irrigation Solution is intended for cleansing and moistening wounds, for the management of acute and chronic wounds including ulcers, burns, post-surgical wounds and abrasions. Chronic skin wounds are mainly characterised by the presence of slough, necrotic tissue and/or microbial biofilms. Microbial biofilms are notoriously difficult to remove and lead to delays in wound healing. WoundSan® Irrigation Solution can help to mechanically remove these barriers of wound healing through its cleansing and mechanical activity. WoundSan® Irrigation Solution has been tested in vitro against a wide range of multispecies biofilms (bacteria, yeasts and fungi) that may retard healing.
Fast Acting (less than 5 minutes)
Low Cytotoxicity
Advanced Biofilm Disruption and Prevention Capabilities

START / AT THE RIGHT POINT

Benefit from Eumar’s agility, process innovation and supply chain resilience wherever you are on your product development journey.

Discuss a project